Answer
Logynon increases venous blood clot risk compared with not using combined hormonal contraception, although it is among the lowest-risk combined hormonal contraceptives; risk is highest in the first year and may increase when restarting after a break of four weeks or more.
Sources for this answer
- LogynonBayer plc · emc · SmPC §4.4 Special warnings and precautions for use · Version 21Document updated
Sources checked